Skip to main content
. 2025 May 15;19:3857–3882. doi: 10.2147/DDDT.S512058

Figure 13.

Figure 13

2D presentation of the most favorable binding poses and ligand interactions into the active site of TGF-β (PDB: 1VJY) (A) Co-crystallized ligand. (B) Celecoxib. (C) analog HR1. (D) analog HR2. (E) analog HR3.